Literature DB >> 10828793

Frey syndrome treatment with botulinum toxin.

P Dulguerov1, D Quinodoz, G Cosendai, P Piletta, W Lehmann.   

Abstract

The goal of this work is to present our results of the intradermic infiltration with botulinum toxin in patients with Frey syndrome. Sixteen hemifaces in 15 patients were studied. Gustatory stimulation was evoked by sucking on a slice of lemon while measurements were done on both hemifaces, with the normal side being used as a control. Skin temperature and color (erythema) were measured with a digital surface thermometer and a skin chromameter, respectively. Sweat quantity and surface were measured by using the previously described blotting paper and iodine-sublimated paper histogram methods, respectively. Testing was repeated 2 weeks after skin infiltration with botulinum toxin (dilution of 50 U/mL). The interinjection distances were 1 cm, and 0.1 mL (5 U) was infiltrated at each injection site. Frey syndrome complaints disappeared in all patients. Small residual amounts of sweat were measurable. The difference in sweat quantity before and after botulinum toxin infiltration was significant in every patient (P < 0.001). Skin temperature and color measurement gave inconclusive results. In conclusion, Frey syndrome treatment with botulinum toxin is an efficient and well-tolerated technique. Further work should address the optimal injection parameters.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828793     DOI: 10.1016/S0194-59980070008-8

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  5 in total

1.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

2.  [Botulinum toxin for treatment of gustatory sweating. A prospective randomized study].

Authors:  D Nolte; I Gollmitzer; D J Loeffelbein; F Hölzle; K-D Wolff
Journal:  Mund Kiefer Gesichtschir       Date:  2004-10-29

3.  Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles.

Authors:  Shang Xie; Kan Wang; Tao Xu; Xue-Sheng Guo; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Cancer Med       Date:  2015-08-26       Impact factor: 4.452

4.  The Effects of Superficial Musculoaponeurotic System Flap on the Development of Frey's Syndrome and Cosmetic Outcomes After Superficial Parotidectomy.

Authors:  Ömer Bayır; Elif Kaya Çelik; Güleser Saylam; Emel Çadallı Tatar; Cem Saka; Muharrem Dağlı; Ali Özdek; Mehmet Hakan Korkmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-12-01

5.  Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats.

Authors:  Matteo Runfola; Simone Rossi; Simona Panunzi; Pier Luigi Spada; Daniele Gui
Journal:  BMC Gastroenterol       Date:  2003-09-10       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.